Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of human prostate cancer cell line to determine Ebp1 effect in prostate cancer


ABSTRACT: Therapies targeting the androgen receptor are critical for treatment of hormone refractory prostate cancer. We have previously demonstrated that Ebp1, a protein isolated by its ability to bind ErbB3, is a downstream effector of heregulin activated pathways and an AR corepressor. As Ebp1 is decreased in preclinical models of hormone refractory prostate cancer, we studied the ability of Ebp1 to mitigate the hormone refractory phenotype. As we previously found that Ebp1 affected the expression of some androgen receptor target genes, we sought to determine a full spectrum of genes changed using an unbiased appraoch by microarry analysis. Experiment Overall Design: A hormone independent cell line C81 was derived from LNCaP cells by long term passage and was a kind gift of Dr. Lin (University of Nebraska). C81 cell were transfected with a vector control or EBP1 expression plasmids and mass cultures selected. RNA was collected from logaritmically growing cultures.

ORGANISM(S): Homo sapiens

SUBMITTER: Anne Hamburger 

PROVIDER: E-GEOD-12200 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.

Zhang Yuexing Y   Linn Douglas D   Liu Zhenqiu Z   Melamed Jonathan J   Tavora Fabio F   Young Charles Y CY   Burger Angelika M AM   Hamburger Anne W AW  

Molecular cancer therapeutics 20081001 10


Aberrant activation of the androgen receptor (AR) by the ErbB2/ErbB3 heterodimer contributes to the development of hormone resistance in prostate cancer. EBP1, an ErbB3-binding protein, acts as an AR corepressor. As EBP1 is decreased in preclinical models of hormone-refractory prostate cancer, we studied the expression of EBP1 in human prostate cancer. We found that the expression of the EBP1 gene was significantly decreased in prostate cancer tissues compared with benign prostate at both mRNA a  ...[more]

Similar Datasets

2009-03-31 | E-GEOD-13718 | biostudies-arrayexpress
2009-03-07 | E-TABM-655 | biostudies-arrayexpress
2019-11-12 | PXD010845 | Pride
2007-10-25 | E-GEOD-6519 | biostudies-arrayexpress
2005-08-01 | E-MEXP-382 | biostudies-arrayexpress
2010-05-25 | E-GEOD-8727 | biostudies-arrayexpress
2008-10-26 | E-GEOD-9488 | biostudies-arrayexpress
2013-07-02 | E-GEOD-45438 | biostudies-arrayexpress
2008-11-04 | E-GEOD-12268 | biostudies-arrayexpress
2013-04-01 | E-GEOD-37225 | biostudies-arrayexpress